Silencing of long non-coding RNA HCP5 inhibits proliferation, invasion, migration, and promotes apoptosis via regulation of miR-299-3p/SMAD5 axis in gastric cancer cells

References

• Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424.
   PubMed Web of Science ®Google Scholar
• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA Cancer J Clin. 2018;68(1):7–30.
   PubMed Web of Science ®Google Scholar
• Hamilton TD, Mahar AL, Haas B, et al. The impact of advanced age on short-term outcomes following gastric cancer resection: an ACS-NSQIP analysis. Gastric Cancer. 2018;21(4):710–719.
   PubMed Web of Science ®Google Scholar
• Zong L, Abe M, Seto Y, et al. The challenge of screening for early gastric cancer in China. Lancet. 2016;388(10060):2606.
   PubMed Web of Science ®Google Scholar
• Yao J, Zhang H, Liu C, et al. miR-450b-3p inhibited the proliferation of gastric cancer via regulating KLF7. Cancer Cell Int. 2020;20(1):47.
   PubMed Web of Science ®Google Scholar
• Astudillo P. Wnt5a signaling in gastric cancer. Front Cell Dev Biol. 2020;8:110.
   PubMed Web of Science ®Google Scholar
• Fernandes JCR, Acuna SM, Aoki JI, et al. Long non-coding RNAs in the regulation of gene expression: physiology and disease. Noncoding RNA. 2019;5(1). DOI:10.3390/ncrna5010017
   PubMed Web of Science ®Google Scholar
• Ponting CP, Oliver PL, Reik W. Evolution and functions of long noncoding RNAs. Cell. 2009;136(4):629–641.
   PubMed Web of Science ®Google Scholar
• Yu Y, Shen HM, Fang DM, et al. LncRNA HCP5 promotes the development of cervical cancer by regulating MACC1 via suppression of microRNA-15a. Eur Rev Med Pharmacol Sci. 2018;22(15):4812–4819.
   PubMed Web of Science ®Google Scholar
• Wang L, Luan T, Zhou S, et al. LncRNA HCP5 promotes triple negative breast cancer progression as a ceRNA to regulate BIRC3 by sponging miR-219a-5p. Cancer Med. 2019;8(9):4389–4403.
   PubMed Web of Science ®Google Scholar
• Hu R, Lu Z. Long noncoding RNA HCP5 promotes prostate cancer cell proliferation by acting as the sponge of miR4656 to modulate CEMIP expression. Oncol Rep. 2020;43(1):328–336.
   PubMed Web of Science ®Google Scholar
• Mo X, Wu Y, Chen L, et al. Global expression profiling of metabolic pathway-related lncRNAs in human gastric cancer and the identification of RP11-555H23.1 as a new diagnostic biomarker. J Clin Lab Anal. 2019;33(2):e22692.
   PubMed Web of Science ®Google Scholar
• Barajas-Casta ١ ed a LM, Cortﺃﺏs-Gutiﺃﺏrrez E, Garcﺃﺝa-Rodrﺃﺝguez FM, et al. Overexpression of MMP-3 and uPA with diminished PAI-1 related to metastasis in ductal breast cancer patients attending a public hospital in Mexico City. J Immunol Res. 2016;2016:8519648.
   PubMed Web of Science ®Google Scholar
• Bodey B, Bodey B Jr., Grﺃ٦ger AM, et al. Invasion and metastasis: the expression and significance of matrix metalloproteinases in carcinomas of the lung. Vivo. 2001;15(2):175–180.
   PubMed Web of Science ®Google Scholar
• Raghav PK, Kumar R, Kumar V, et al. Docking-based approach for identification of mutations that disrupt binding between Bcl-2 and Bax proteins: inducing apoptosis in cancer cells. Mol Genet Genomic Med. 2019;7(11):e910.
   PubMed Web of Science ®Google Scholar
• Bumbat M, Wang M, Liang W, et al. Effects of Me(2)SO and trehalose on the cell viability, proliferation, and Bcl-2 family gene (BCL-2, BAX, and BAD) expression in cryopreserved human breast cancer cells. Biopreserv Biobank. 2020;18(1):33–40.
   PubMed Web of Science ®Google Scholar
• Nie ML, Han J, Huang HC, et al. The novel lncRNA p4516 acts as a prognostic biomarker promoting gastric cancer cell proliferation and metastasis. Cancer Manag Res. 2019;11:5375–5391.
   PubMed Web of Science ®Google Scholar
• Dai Q, Zhang T, Li C. LncRNA MALAT1 regulates the cell proliferation and cisplatin resistance in gastric cancer via PI3K/AKT pathway. Cancer Manag Res. 2020;12:1929–1939.
   PubMed Web of Science ®Google Scholar
• Zaheed O, Samson J, Dean K. A bioinformatics approach to identify novel long, non-coding RNAs in breast cancer cell lines from an existing RNA-sequencing dataset. Noncoding RNA Res. 2020;5(2):48–59.
   PubMed Web of Science ®Google Scholar
• Zhang P, Shi L, Song L, et al. LncRNA CRNDE and lncRNA SNHG7 are promising biomarkers for prognosis in synchronous colorectal liver metastasis following hepatectomy. Cancer Manag Res. 2020;12:1681–1692.
   PubMed Web of Science ®Google Scholar
• Chen P, Zhao X, Wang H, et al. The Down-Regulation of lncRNA PCAT18 Promotes the Progression of Gastric Cancer via MiR-107/PTEN/PI3K/AKT Signaling Pathway. Onco Targets Ther. 2019;12:11017–11031.
   PubMed Web of Science ®Google Scholar
• Shi XY, Sun YZ, Li M, et al. LncRNA CADM1-AS1 serves as a new prognostic biomarker for gastric cancer. Eur Rev Med Pharmacol Sci. 2019;23(3 Suppl):232–238.
   PubMedGoogle Scholar
• Liang L, Xu J, Wang M, et al. LncRNA HCP5 promotes follicular thyroid carcinoma progression via miRNAs sponge. Cell Death Dis. 2018;9(3):372.
   PubMedGoogle Scholar
• Chen X, Qi M, Yang Q, et al. MiR-299-3p functions as a tumor suppressor in thyroid cancer by regulating SHOC2. Eur Rev Med Pharmacol Sci. 2019;23(1):232–240.
   PubMed Web of Science ®Google Scholar
• Yu Y, Zhao JD, Yang H. MiR-299-3p inhibits proliferation and invasion of cervical cancer cell via targeting TCF4. Eur Rev Med Pharmacol Sci. 2019;23(13):5621–5627.
   PubMed Web of Science ®Google Scholar
• Dang S, Zhou J, Wang Z, et al. MiR-299-3p functions as a tumor suppressor via targeting Sirtuin 5 in hepatocellular carcinoma. Biomed Pharmacother. 2018;106:966–975.
   PubMed Web of Science ®Google Scholar
• Li F, Xu Y, Liu RL. SAMD5 mRNA was overexpressed in prostate cancer and can predict biochemical recurrence after radical prostatectomy. Int Urol Nephrol. 2019;51(3):443–451.
   PubMed Web of Science ®Google Scholar
• Li S, Zhao B, Zhao H, et al. Silencing of long non-coding RNA SMAD5-AS1 reverses epithelial mesenchymal transition in nasopharyngeal carcinoma via microRNA-195-dependent inhibition of SMAD5. Front Oncol. 2019;9:1246.
   PubMed Web of Science ®Google Scholar